Skip to main content
SpringerLink
Log in

Microprolactinomas: Why requiem for surgery?

  • Opinion
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Spark R.F., Baker R., Bienfang D.C., Bergland R. Bromocriptine reduces pituitary tumor size and hypersecretion. Requiem for pituitary surgery? JAMA 247: 3111, 1982.

    Article  Google Scholar 

  2. Chiodini P.G., Liuzzi A., Verde G., Cozzi R., Silvestrini F., Marsili M.T., Horowski R., Passerini F., Luccarelli G, Borghi P.G. Size reduction of a PRL secreting adenoma during long term treatment with the dopamine agonist lisuride. International Symposium on Pituitary Microadenomas. Milan, Serono Symposia. Abst 64, 1978.

  3. McGregor A.M., Scanlon M.F. Hallr., Hall K. Effects of bromocriptine on pituitary tumor size. Br. Med. J. 2: 700, 1979.

    Article  Google Scholar 

  4. Serri O., Rasio E., Beauregard H., Hardy J., Somma M. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma. N. Engl. J. Med. 309: 280, 1983.

    Article  PubMed  CAS  Google Scholar 

  5. Moriondo P., Travaglini P., Nissim M., Conti A., Faglia G. Bromocriptine treatment of microprolactinomas: evidence of stable PRL decrease after drug withdrawal. J. Clin. Endocrinol. Metab. 60: 764, 1985.

    Article  PubMed  CAS  Google Scholar 

  6. Landolt A.M., Keller P.J., Froesch E.R. Bromocriptine: does it jeopardise the results of later surgery for prolactinomas? Lancet 2: 657, 1982.

    Article  PubMed  CAS  Google Scholar 

  7. Gen M., Uozumi T., Ohta M., Ito A., Hajiwara H., Mori S. Necrotic changes in prolactinomas after long-term administration of bromocriptine. J. Clin. Endocrinol. Metab. 59: 463, 1984.

    Article  PubMed  CAS  Google Scholar 

  8. Molitch M.E. Pathologic hyperprolactinemia. Endocrinol. Metab. Clin. North Am. ?: 877, 1992.

  9. Webster J., Page M.D., Bevan J.S., Richard S.H., Douglas-Jones A.G., Scanlon M.F. Low recurrence rate after partial hypophysectomy for prolactinomas, the predictive value of dynamic function tests. Clin. Endocrinol. (Oxf.) 36: 35, 1992.

    Article  CAS  Google Scholar 

  10. Losa M., Mortini P., Gugni E., Acerno S., Giovannelli M. Neurosurgical treatment of pituitary microadenomas: analysis of safety and efficacy in more than 200 cases. J. Endocrinol. Invest. 18 (Suppl.) abst 45, 1995.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Endocrinology, Ospedale Casa Sollievo della Sofferenza, IRCCS, 71013, San Giovanni Rotondo, Italy

    A. Liuzzi & G. Oppizzi

Authors
  1. A. Liuzzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Oppizzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported by Grant no. of the Special Research Program Clinical Applications of the Oncological Research by National Research Council, Italy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liuzzi, A., Oppizzi, G. Microprolactinomas: Why requiem for surgery?. J Endocrinol Invest 19, 196–198 (1996). https://doi.org/10.1007/BF03349866

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349866

Key-words

Search

Navigation